Scarica l'app Stockscreener
13.35
0.67%
-0.09
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché RDY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$13.44
Aprire:
$13.26
Volume 24 ore:
1.53M
Relative Volume:
0.94
Capitalizzazione di mercato:
$2.22B
Reddito:
$3.47B
Utile/perdita netta:
$668.83M
Rapporto P/E:
3.3269
EPS:
4.0127
Flusso di cassa netto:
$253.46M
1 W Prestazione:
-1.84%
1M Prestazione:
-9.80%
6M Prestazione:
-20.73%
1 anno Prestazione:
-11.76%
Intervallo 1D:
$13.18
$13.36
Intervallo di 1 settimana:
$13.16
$13.65
Portata 52W:
$13.16
$16.89
Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile
Confronta RDY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RDY
Dr Reddys Laboratories Ltd Adr
|
13.35 | 2.22B | 3.47B | 668.83M | 253.46M | 4.0127 |
|
ZTS
Zoetis Inc
|
160.46 | 71.85B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.08 | 45.58B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.58B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.74 | 19.18B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.60 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-19 | Downgrade | Nomura | Buy → Neutral |
| 2024-01-11 | Downgrade | Jefferies | Buy → Underperform |
| 2023-08-29 | Downgrade | HSBC Securities | Buy → Hold |
| 2023-05-18 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-03-17 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-01-30 | Iniziato | JP Morgan | Underweight |
| 2022-11-14 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2022-01-03 | Ripresa | BofA Securities | Neutral |
| 2021-07-27 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2021-02-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-09-18 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-09-18 | Aggiornamento | Investec | Sell → Hold |
| 2020-01-28 | Downgrade | CLSA | Buy → Outperform |
| 2020-01-27 | Downgrade | CLSA | Buy → Outperform |
| 2020-01-09 | Aggiornamento | Citigroup | Sell → Buy |
| 2019-11-04 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-09-04 | Aggiornamento | Credit Suisse | Underperform → Outperform |
| 2019-07-01 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2019-06-20 | Iniziato | Deutsche Bank | Hold |
| 2019-06-11 | Iniziato | Barclays | Equal Weight |
| 2019-05-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-02-19 | Aggiornamento | CLSA | Outperform → Buy |
| 2019-01-17 | Downgrade | Citigroup | Neutral → Sell |
| 2017-09-21 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-08-31 | Aggiornamento | CLSA | Underperform → Outperform |
| 2017-07-28 | Downgrade | CLSA | Underperform → Sell |
| 2016-07-27 | Downgrade | HSBC Securities | Hold → Reduce |
| 2016-07-27 | Downgrade | Jefferies | Hold → Underperform |
| 2016-02-10 | Aggiornamento | Credit Agricole | Underperform → Buy |
| 2015-11-10 | Downgrade | Citigroup | Buy → Neutral |
Mostra tutto
Dr Reddys Laboratories Ltd Adr Borsa (RDY) Ultime notizie
Its Stock Has Paid Off Big Time For Dr. Reddy’s Laboratories Ltd. ADR - SETE News
Marshall Wace, DE Shaw, Millennium Helped Drive China ADR Surges - Mint
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading; End Week Up 2% - TradingView
Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - TradingView
Indian ADRs Alert! Why Infosys, Wipro, HDFC Bank, ICICI Bank, Dr Reddy's Lab Will Be In Focus On February 13? - Goodreturns
Taking on analysts’ expectations and winning: Dr. Reddy’s Laboratories Ltd. ADR (RDY) - SETE News
Dr. Reddy’s Laboratories Ltd. ADR [NYSE: RDY] Sees Decrease in Stock Value - Knox Daily
Nothing is Better Than Sociedad Quimica Y Minera de Chile S.A. ADR (SQM) stock at the moment - SETE News
Ecolab, Inc (ECL) expanding its growth trajectory ahead - SETE News
A look into Golar Lng (GLNG)’s deeper side - SETE News
Altria Group Inc [NYSE: MO] Sees Increase in Stock Value - Knox Daily
Moody’s Corp [MCO] Shares Jump Approximately 26.66% Over the Year - Knox Daily
Understanding the 1.67% Volatility Levels of Dr. Reddy’s Laboratories Ltd. ADR’s (RDY) Stock in the Past 30 Days - The News Heater
LLY Stock Quote Price and Forecast - CNN
Asian Equities Traded in the US as ADRs Rise in Tuesday Trading - MSN
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Dr Reddy's Labs shares slide 6% post Q3 results. Should you buy, sell, or hold? - The Economic Times
Dr. Reddy’s Labs ADR earnings missed by $0.02, revenue fell short of estimates - Investing.com
Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business - Benzinga
Coupang Inc (NYSE: CPNG): A Blank Check? - Stocks Register
Dr. Reddys Lab, Mankind Pharma, Adani Energy Solutions, Indus Towers—Earnings Estimates - NDTV Profit
Dr Reddy's Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth - Moneycontrol
Week Ahead: Q3 Results, FII flow, Donald Trump inauguration, global cues among key market triggers for Sensex, Nifty - Mint
Infosys shares fall 4% after wage hike impact on margins overshadow guidance raise - CNBCTV18
Stock Market News Today highlights on January 16, 2025 : Stock exchanges ban fresh F&O positions in Kalyan Jewellers | Stock Market News - Mint
Dr. Reddy's Laboratories12 stocks trade against tide, hover near their 52-week high - The Economic Times
GAMMA Investing LLC Has $107,000 Position in Dr. Reddy’s Laboratories Limited (NYSE:RDY) - Defense World
Guess who’s the richest MLA in outgoing Delhi assembly? Hint – it’s NOT Kejriwal, Atishi or Sisodia | Mint - Mint
Dr Reddy Share Price Highlights : Dr Reddy closed today at ₹1374.1, up 1.73% from yesterday's ₹1350.75 | Stock Market News - Mint
Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Sold by JPMorgan Chase & Co. - MarketBeat
Asian Equities Traded in the US as ADRs Rise in Thursday Trading - MSN
Buy Dr Reddy's & IRB Infra shares; sell JSW Energy stock, says YES Securities - Business Today
Asian Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading - MSN
Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading - MSN
Where is Dr Reddy's Share Price Headed in 2025? - Equitymaster
Weekly Upgrades and Downgrades - InvestorPlace
Stock Market News Today Live Updates on December 20, 2024 : Top Gainers and Losers today on 20 December, 2024: Dr Reddys Laboratories, ICICI Bank, Tech Mahindra, Trent among most active stocks; Check full list here | Stock Market News - Mint
Dr Reddy’s shares jump over 4 per cent on upgrade by NomuraMarket News - The Financial Express
Zopiclone Market Forecast: Trends and Investment - openPR
Dr Reddy's Laboratories Share Price Live Updates: Disclosure Under Regulation 30 Of SEBI (LODR) Regulatio... - The Economic Times
Dr Reddy’s will top up base business with innovation in India: M V Ramana - BusinessLine
ADR, GDR Listings of Indian companies - Goodreturns
Asian Equities Traded in the US as American Depositary Receipts Edge Down in Wednesday Trading - MSN
NVO Stock Quote Price and Forecast - CNN
Dr Reddy's Labs tanks over 3% after USFDA inspects Hyderabad API facility - Business Standard
Stocks to watch on November 21: Adani Group stocks, Dr Reddy's, Godrej Properties, Tata Power, GRSE, UPL, Bharti Airtel - Upstox
Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading - MSN
Dr Reddy's shares fall 3% as pharma major receives 7 observations from USFDA; check details - Upstox
Asian Equities Traded in the US as American Depositary Receipts Flat in Tuesday Trading - MSN
Asian Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading - MSN
Jharkhand Elections Phase 2: Richest candidate declares assets worth Rs 402 cr – Check list of top 10 wealthiest candidates - The Financial Express
Dr Reddys Laboratories Ltd Adr Azioni (RDY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.23%
3.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):